These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18779624)

  • 1. Sweet syndrome associated with granulocyte colony-stimulating factor.
    Bidyasar S; Montoya M; Suleman K; Markowitz AB
    J Clin Oncol; 2008 Sep; 26(26):4355-6. PubMed ID: 18779624
    [No Abstract]   [Full Text] [Related]  

  • 2. Images in haematology. Sweet's syndrome after granulocyte colony-stimulating factor administration for refractory myelodysplastic syndrome.
    Matsumura T; Kami M
    Br J Haematol; 2001 Apr; 113(1):1. PubMed ID: 11328271
    [No Abstract]   [Full Text] [Related]  

  • 3. Granulocyte colony-stimulating factor-induced Sweet syndrome in a healthy donor.
    Oiso N; Watanabe K; Kawada A
    Br J Haematol; 2006 Oct; 135(2):148. PubMed ID: 16856884
    [No Abstract]   [Full Text] [Related]  

  • 4. Cutaneous manifestations of granulocyte colony-stimulating factor.
    White JM; Mufti GJ; Salisbury JR; du Vivier AW
    Clin Exp Dermatol; 2006 Mar; 31(2):206-7. PubMed ID: 16487091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sweet syndrome following therapeutic use of granulocyte colony stimulating factor].
    Veres K; Haraszti A; Nemes Z; Zeher M
    Orv Hetil; 1999 May; 140(19):1059-61. PubMed ID: 10339998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sweet syndrome associated with G-CSF treatment in a child with glycogen storage disease type Ib.
    Garty BZ; Levy I; Nitzan M; Barak Y
    Pediatrics; 1996 Mar; 97(3):401-3. PubMed ID: 8604280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous splenic rupture with fatal outcome following G-CSF administration for myelodysplastic syndrome.
    O'Malley DP; Whalen M; Banks PM
    Am J Hematol; 2003 Aug; 73(4):294-5. PubMed ID: 12879437
    [No Abstract]   [Full Text] [Related]  

  • 8. The Sweet syndrome during therapy with granulocyte colony-stimulating factor.
    Park JW; Mehrotra B; Barnett BO; Baron AD; Venook AP
    Ann Intern Med; 1992 Jun; 116(12 Pt 1):996-8. PubMed ID: 1375012
    [No Abstract]   [Full Text] [Related]  

  • 9. Dramatic hyperleukocytosis after treatment of myelodysplastic syndrome with pegfilgrastim and darbepoetin-alfa.
    Heydrich BN; Schoch R; Horst HA; Kneba M
    Ann Hematol; 2008 Jan; 87(1):77-8. PubMed ID: 17710399
    [No Abstract]   [Full Text] [Related]  

  • 10. An assessment of erythroid response to epoetin alpha as a single agent versus in combination with granulocyte- or granulocyte-macrophage-colony-stimulating factor in myelodysplastic syndromes using a meta-analysis approach.
    Mundle S; Lefebvre P; Vekeman F; Duh MS; Rastogi R; Moyo V
    Cancer; 2009 Feb; 115(4):706-15. PubMed ID: 19152429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid disease progression in two cases of myelodysplastic syndrome (MDS) following short therapy with G-CSF.
    Zomas A; Fisfis M; Stefanoudaki-Sofianatou K
    Haematologica; 1997; 82(2):253-4. PubMed ID: 9175335
    [No Abstract]   [Full Text] [Related]  

  • 12. [Neutrophilic dermatosis due to granulocyte-colony stimulating factor].
    Izquierdo Herce N; Fernández López E; Roncero Riesco M; Zafra Cobo I
    Med Clin (Barc); 2008 Jun; 131(2):80. PubMed ID: 18588837
    [No Abstract]   [Full Text] [Related]  

  • 13. Sweet syndrome associated with intrahepatic cholangiocarcinoma producing granulocyte colony-stimulating factor.
    Shinojima Y; Toma Y; Terui T
    Br J Dermatol; 2006 Nov; 155(5):1103-4. PubMed ID: 17034566
    [No Abstract]   [Full Text] [Related]  

  • 14. Unusual extramedullary hematopoiesis in a patient receiving granulocyte colony-stimulating factor.
    Dagdas S; Ozet G; Alanoglu G; Ayli M; Gokmen Akoz A; Erekul S
    Acta Haematol; 2006; 116(3):198-202. PubMed ID: 17016039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute myeloid leukaemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
    Ferretti G; Papaldo P
    Breast Cancer Res Treat; 2008 May; 109(1):187-8. PubMed ID: 17616805
    [No Abstract]   [Full Text] [Related]  

  • 16. Pegfilgrastim-induced Sweet's syndrome: a case report.
    Machan M; Matthys B; Fraga GR
    Int J Dermatol; 2014 Oct; 53(10):1275-7. PubMed ID: 23330634
    [No Abstract]   [Full Text] [Related]  

  • 17. Combined use of erythropoietin and G-CSF in the treatment of myelodysplastic syndromes.
    Haematologica; 1999 Dec; 84(12):1057. PubMed ID: 10586204
    [No Abstract]   [Full Text] [Related]  

  • 18. Bullous pyoderma gangrenosum in a patient with myelodysplastic syndrome during granulocyte colony-stimulating factor therapy.
    Lewerin C; Mobacken H; Nilsson-Ehle H; Swolin B
    Leuk Lymphoma; 1997 Aug; 26(5-6):629-32. PubMed ID: 9389372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bullous Sweet's syndrome after granulocyte colony-stimulating factor therapy in a child with congenital neutropenia.
    Akilov OE; Desai N; Jaffe R; Gehris RP
    Pediatr Dermatol; 2014; 31(2):e61-2. PubMed ID: 24387761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azacitidine: a new medication associated with Sweet syndrome.
    Tintle S; Patel V; Ruskin A; Halasz C
    J Am Acad Dermatol; 2011 May; 64(5):e77-9. PubMed ID: 21496689
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.